Hullam, Gabor
Antal, Peter http://orcid.org/0000-0002-4370-2198
Petschner, Peter http://orcid.org/0000-0002-3198-858X
Gonda, Xenia http://orcid.org/0000-0001-9015-4203
Bagdy, Gyorgy
Deakin, Bill http://orcid.org/0000-0002-2750-962X
Juhasz, Gabriella http://orcid.org/0000-0002-5975-4267
Article History
Received: 9 December 2018
Accepted: 19 June 2019
First Online: 5 July 2019
Competing Interests
: Prof. Deakin has variously performed consultancy, speaking engagements, and research for Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Schering Plough, Janssen-Cilag, and Servier (all fees are paid to the University of Manchester to reimburse them for the time taken); he also has share options in P1vital. The other authors report no conflict of interest.